Elevated prothrombin time/international normalized ratio associated with concurrent administration of regorafenib and warfarin in a patient with advanced colorectal cancer
Crossref DOI link: https://doi.org/10.1186/s40780-016-0050-y
Published Online: 2016-07-08
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kitade, Hironori
Hiromasa-Yamasaki, Azusa
Hokkoku, Kengo
Mori, Mitsue
Watanabe, Michio
Nakai, Masuo
Yano, Seiji